Get the Stockscreener App
1.20
2.43%
0.00
Connect Biopharma Holdings Ltd Adr stock is traded at $1.20, with a volume of 7,963.
It is up +2.43% in the last 24 hours and down -12.83% over the past month.
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
See More
Previous Close:
$1.20
Open:
$1.245
24h Volume:
7,963
Relative Volume:
0.29
Market Cap:
$66.30M
Revenue:
-
Net Income/Loss:
$-85.88M
P/E Ratio:
-0.765
EPS:
-1.5686
Net Cash Flow:
$-80.96M
1W Performance:
+2.43%
1M Performance:
-12.83%
6M Performance:
-22.70%
1Y Performance:
-18.60%
1-Day Range:
$1.20
$1.28
1-Week Range:
$1.1502
$1.40
52-Week Range:
$0.6777
$2.84
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Company Profile
Name
Connect Biopharma Holdings Ltd Adr
Sector
Industry
Phone
-
Address
-
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-21 | Initiated | Jefferies | Buy |
| Apr-13-21 | Initiated | Piper Sandler | Overweight |
| Apr-13-21 | Initiated | SVB Leerink | Outperform |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Latest News
Connect Biopharma shares hold at Buy after FDA meeting - Investing.com
Analyzing Stride (NYSE:LRN) & Visionary (NASDAQ:GV) - Defense World
CNTB Stock on the Rise: A Promising Investment - The InvestChronicle
Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum - GlobeNewswire Inc.
Ratios in Focus: Analyzing Connect Biopharma Holdings Ltd ADR (CNTB)'s Price-to-Cash and Price-to-Free Cash ... - The Dwinnex
Connect Biopharma appoints new CEO and President By Investing.com - Investing.com
Market Watch: Connect Biopharma Holdings Ltd ADR (CNTB)'s Noteworthy Drop, Closing at 1.76 – DWinneX - The Dwinnex
Connect Biopharma shares target raised on strategic focus By Investing.com - Investing.com
Are Medical Stocks Lagging Bausch Health (BHC) This Year? - MSN
Has Connect Biopharma Holdings (CNTB) Outpaced Other Medical Stocks This Year? - Yahoo Finance UK
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.81% By Investing.com - Investing.com
Making it harder to "buy" China, Inc. - US-China Institute
Connect Biopharma Holdings Limited: Shareholders Board Members Managers and Company Profile | US2075231017 - Marketscreener.com
Connect Biopharma (CNTB) Stock Price, News & Analysis - MarketBeat
BioLine Rx (NASDAQ:BLRX) Stock Quotes, Forecast and News Summary - Benzinga
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):